ALEXANDRIA CO. FOR PHARMACEUTICALS & CHEMICAL INDUSTRIES

Alexandria Co. For Pharmaceuticals & Chemical Industries

AXPH

EGS38341C011

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
220.9 ^EGP	-0.41%		-2.24%	+23.94%

2023	Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023	CI
2022	Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022	CI

Alexandria Co. for Pharmaceuticals & Chemical Industries Reports Reviewed Earnings Results for the Period Ended December 31, 2018

February 11, 2019

Alexandria Co. For Pharmaceuticals & Chemical Industries reported reviewed earnings results for the period ended December 31, 2018. For the period the company reported net profit of EGP 72,260,702 compared to EGP 71,835,068 a year ago.

Latest news about Alexandria Co. For Pharmaceuticals & Chemical Industries

Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 14	CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-19	CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2022	22-05-22	CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-14	CI
VAlexandria Pharmaceuticals Announces Consolidated Earnings Results for the Six Months Ended December 31, 2020	21-02-15	CI
Alexandria Co. for Pharmaceuticals and Chemical Industries Recommends Cash Dividend for Fiscal Year 2019/2020	20-08-25	CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Announces Earnings Results for the Year Ended on 30 June 2020	20-08-25	CI
Alexandria Pharmaceuticals Announces Earnings Results for the Year Ended June 30, 2019	19-09-29	CI
Alexandria Co. for Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2018	19-05-13	CI
Alexandria Co. for Pharmaceuticals & Chemical Industries Reports Reviewed Earnings Results for the Period Ended December 31, 2018	19-02-11	CI
Alexandria Pharmaceuticals Reports Earnings Results for the Three Months Ended September 30, 2018	18-11-12	CI
Alexandria Pharmaceuticals Declares Cash Dividend, Payable on October 28, 2018	18-10-08	CI
Alexandria Pharmaceuticals Announces Audited Earnings Results for the Year Ended June 30, 2018	18-10-03	CI
Alexandria Pharmaceuticals Announces Earnings Results for the Nine Months Ended March 31, 2018	18-05-12	CI
Alexandria Pharmaceuticals Reports Earnings Results for the Half Year Ended December 31, 2017	18-02-13	CI
Alexandria Pharmaceuticals Announces Audited Earnings Results for the Year Ended September 30, 2017	17-11-11	CI
Alexandria Pharmaceuticals Announces Audited Earnings Results for the Year Ended June 30, 2017	17-10-07	CI
Alexandria Pharmaceuticals Declares Cash Dividend, Payable on October 26, 2017	17-10-07	CI
Alexandria Pharmaceuticals Reports Audited Earnings Results for the Year Ended June 30, 2017	17-09-05	CI
Alexandria Pharmaceuticals Announces Earnings Results for the Nine Months Ended March 31, 2017	17-05-13	CI
Alexandria Pharmaceuticals Reports Earning Results for the Six Months Ended December 31, 2016	17-02-12	CI
Alexandria Pharmaceuticals and Chemical Industries Co. Announces Earnings Results for the Quarter Ended September 2014	14-10-31	CI
Alexandria Pharmaceuticals and Chemical Industries Co. Announces Earnings Results for the Year Ended June 30, 2014	14-09-30	CI

Chart Alexandria Co. For Pharmaceuticals & Chemical Industries

Duration

Period

Chart Alexandria Co. For Pharmaceuticals & Chemical Industries

More charts

Company Profile

Alexandria Co. for Pharmaceuticals & Chemical Industries SAE specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of inflammatory, infectious, pulmonary, dermatological, cardiovascular, allergic, epileptic, gastrointestinal diseases, etc. The group also provides veterinary and medical products (adhesive tape, gauze compresses, gloves, traction kits, etc.).

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ALEXANDRIA CO. FOR PHARMACEUTICALS & CHEMICAL INDUSTRIES	+23.94%	23.06M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals